Earlier this year, two new drugs that have been shown in global trials to slow early-stage Alzheimer's disease, donanemab and ...
Dementia is a condition that results in progressive memory or thinking problems. It's now the most common cause of death in ...
An Alzheimer’s drug that clears away plaque build-up in the brain could slow progression of the disease and delay the onset of symptoms, early trials have shown. There is currently no cure for the ...
The European Union on Thursday approved the highly contentious Alzheimer's medication Kisunla under strict conditions, with ...
A new drug could halt the progression of Alzheimer’s disease. Trials suggest the treatment, called trontinemab, could be the most powerful weapon yet against dementia. Research will now examine ...
Eli Lilly’s (LLY) weight-loss medications may have benefits for people suffering from Alzheimer’s disease, according to new ...
New Alzheimer’s drugs known as anti-amyloid therapies may slow disease progression—but they also carry serious risks, ...
The US Food and Drug Administration on Monday approved the use of the experimental drug aducanumab for early phases of Alzheimer's disease -- despite an FDA advisory committee concluding last year ...
Australia's medicines watchdog has approved Alzheimer's drug lecanemab, which has been shown to "significantly" extend ...
Controversial1 Alzheimer’s drug lecanemab has overcome another regulatory hurdle, with Australia’s drugs regulator approving the therapy after two rejections.2 The drug, made by Eisai, faces an uphill ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback